0001654954-20-004346 Sample Contracts

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.
Purchase Agreement • April 23rd, 2020 • Edesa Biotech, Inc. • Pharmaceutical preparations

Purchase Agreement dated April 17, 2020 between NovImmune SA Chemin des Aulx 14, 1228 Plan-les-Ouates, Switzerland (hereinafter NI) and Edesa Biotech Research, Inc. 100 Spy Court, Markham, Ontario, Canada, L3R 5H6 (hereinafter Edesa)

AutoNDA by SimpleDocs
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 23rd, 2020 • Edesa Biotech, Inc. • Pharmaceutical preparations • London

This Securities Purchase Agreement (this “Agreement”) is dated as of April 17, 2020, between Edesa Biotech, Inc., a British Columbia corporation (the “Company”), and NovImmune SA (“Purchaser”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!